{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:43:23Z","timestamp":1776473003500,"version":"3.51.2"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T00:00:00Z","timestamp":1607212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01 CA102713"],"award-info":[{"award-number":["1R01 CA102713"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008634","name":"University of Texas at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006667","name":"Health Sciences Center, University of Oregon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007492","name":"Baylor University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007179","name":"University of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.eclinm.2020.100693","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:54:00Z","timestamp":1608717240000},"page":"100693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997\u20132019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)"],"prefix":"10.1016","volume":"31","author":[{"given":"Charles L.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamia","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Lubaczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Vemula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartlett J.","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley C","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Yarnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry C.","family":"Ausdenmoore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgne","family":"Herring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ventrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Aldaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Hrushesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Restaino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik S.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Yarnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Migliorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadi","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June M.","family":"McKoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Tony","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2020.100693_bib0001","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","article-title":"Serious adverse drug events reported to the food and drug administration, 1998-2005","volume":"167","author":"Moore","year":"2007","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.eclinm.2020.100693_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219521","article-title":"Caveat Medicus: clinician experiences in publishing reports of serious oncology-associated adverse drug reactions","volume":"14","author":"Bennett","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2020.100693_bib0003","unstructured":"Canadian Association of University Professors. The Olivieri Report. 2001. https:\/\/www.caut.ca\/docs\/af-reports-indepedent-committees-of-inquiry\/the-olivieri-report.pdf?sfvrsn=0 (Accessed September 4, 2020)."},{"issue":"2","key":"10.1016\/j.eclinm.2020.100693_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211942","article-title":"Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox","volume":"14","author":"Olivieri","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2020.100693_bib0005","first-page":"149","article-title":"Systematic approach to pharmacovigilance beyond the limits: the southern network on adverse reactions (SONAR) projects","volume":"3","author":"Lu","year":"2014","journal-title":"Adv Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.eclinm.2020.100693_bib0006","series-title":"A first book of algebra, including the binomial theorem","author":"Rossiter","year":"2011"},{"key":"10.1016\/j.eclinm.2020.100693_bib0007","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0008","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0009","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","article-title":"Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy","volume":"94","author":"Vansteenkiste","year":"2002","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.eclinm.2020.100693_bib0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0011","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2020.100693_bib0012","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0013","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","article-title":"Breast cancer trial with erythropoietin terminated unexpectedly","volume":"4","author":"Leyland-Jones","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367-","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0015","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0017","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J of Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0018","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofacial Surgery"},{"key":"10.1016\/j.eclinm.2020.100693_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209821","article-title":"Fluoroquinolone-induced serious, persistent, multi-symptom adverse effects","author":"Golomb","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"Suppl 3","key":"10.1016\/j.eclinm.2020.100693_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2106\/JBJS.K.01220","article-title":"A multinational assessment of metal-on- metal bearings in hip replacement","volume":"93","author":"Graves","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.eclinm.2020.100693_bib0021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2141.2003.04448.x","article-title":"Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study","volume":"122","author":"Hedenus","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0022","first-page":"1104","volume":"4","author":"Grobner","year":"2006"},{"key":"10.1016\/j.eclinm.2020.100693_bib0023","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0024","doi-asserted-by":"crossref","first-page":"1040\u20101050","DOI":"10.1200\/JCO.2007.14.2885","article-title":"Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double\u2010blind, placebo\u2010controlled study","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100693_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0026","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2020.100693_bib0027","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2020.100693_bib0028","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0029","series-title":"National Joint Registry for England and Wales","author":"Emsley","year":"2020"},{"key":"10.1016\/j.eclinm.2020.100693_bib0030","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"357","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1359-6349(07)70099-X","volume":"5","author":"Overgaard","year":"2007","journal-title":"Eur J Cancer Suppl"},{"key":"10.1016\/j.eclinm.2020.100693_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clinthera.2015.11.012","article-title":"Effectiveness of darbepoetin alfa for chemotherapy-induced anemia when Initiated at h \u226410g\/dL","volume":"38","author":"Pirker","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.eclinm.2020.100693_bib0033","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0034","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0035","volume":"104","author":"Vadhan-Raj","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2020.100693_bib0036","unstructured":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine. U.S. department of health and human services interim public health recommendations, 1997. cdc.gov\/mmwr\/preview\/mmwrhtml\/00049815.htm (Accessed July 21, 2020)"},{"key":"10.1016\/j.eclinm.2020.100693_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12788\/jcso.0167","article-title":"Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network","volume":"14","author":"Kaur","year":"2016","journal-title":"J Community Support Oncol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0038","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofacial Surgery"},{"key":"10.1016\/j.eclinm.2020.100693_bib0039","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"CREATE investigators. normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0040","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Adenomatous polyp prevention on Vioxx (APPROVe) trial investigators. cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eclinm.2020.100693_bib0041","article-title":"Research ties diabetes drug to heart woes","author":"Harris","year":"2010","journal-title":"New York Times"},{"key":"10.1016\/j.eclinm.2020.100693_bib0042","article-title":"The implants loophole","author":"Meier","year":"2010","journal-title":"New York Times"},{"key":"10.1016\/j.eclinm.2020.100693_bib0043","article-title":"High profile doctor to leave position at Cleveland Clinic","author":"Saul","year":"2006","journal-title":"New York Times"},{"key":"10.1016\/j.eclinm.2020.100693_bib0044","article-title":"Suits use Yale study tying PPA to strokes","author":"Brady","year":"2004","journal-title":"Yale Daily News"},{"key":"10.1016\/j.eclinm.2020.100693_bib0045","unstructured":"Grant B. Kertufflle over anti-shock paper. https:\/\/www.the-scientist.com\/the-nutshell\/kerfuffle-over-antishock-drug-paper-40640 (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0046","unstructured":"Leigh D. US Drug firm drops libel action against scientist. 2000 https:\/\/www.theguardian.com\/science\/2010\/feb\/18\/ge-healthcare-henrik-thomsen-libel (Accessed July 23, 2020)"},{"key":"10.1016\/j.eclinm.2020.100693_bib0047","article-title":"Doctor enourage end of use of heart surgery dru","author":"Grady","year":"2006","journal-title":"New York Times"},{"key":"10.1016\/j.eclinm.2020.100693_bib0048","series-title":"Dispensing with the truth","first-page":"91","author":"Mundy","year":"2001"},{"key":"10.1016\/j.eclinm.2020.100693_bib0049","article-title":"Glaxo sets aside $3.4 Billion on legal problems","author":"Wilson","year":"2011","journal-title":"New York Times"},{"key":"10.1016\/j.eclinm.2020.100693_bib0050","article-title":"10, 000 avandia lawsuits settled for $460 million while FDA considers possible avandia recall","author":"Lamb","year":"2010","journal-title":"Drug Injury Watch"},{"key":"10.1016\/j.eclinm.2020.100693_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/450324b","article-title":"Merck settles Vioxx lawsuits for $4.85 billion","author":"Wadman","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.eclinm.2020.100693_bib0052","unstructured":"Settlement agreement. DePuy orthopedics incorporated. 2015. https:\/\/www.usasrhipsettlement.com\/Un-Secure\/Docs\/Final_2015_ASR_Settlement_Agreement.pdf (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0053","unstructured":"Smethie D., Heilshoren R. Hip replacement verdicts and settlements: updated. 2019. https:\/\/www.balancedbridge.com\/blog\/hip-replacement-lawsuits. (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0054","unstructured":"The $22 billion gold rush. Fortune 2006, https:\/\/www.forbes.com\/forbes\/2006\/0410\/086.html#6b7a774548d4 (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0055","unstructured":"Cohen J., Phillips L. Pfizer's record-breaking $2.3 billion settlement today. https:\/\/www.phillipsandcohen.com\/bextra-whistleblower-case-leads-record-setting-pfizer-settlement\/#:~:text=The%20largest%20piece%20of%20the,both%20relating%20to%20 (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0056","unstructured":"Department of Justice. Justice department announces largest health care fraud settlement in its history: pfizer to pay $2.3 billion for fraudulent marketing. 2009. https:\/\/www.justice.gov\/opa\/pr\/justice-department-announces-largest-health-care-fraud-settlement-its-history (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0057","unstructured":"Department of Justice. US pharmaceutical company merck sharp and dohme to pay nearly one billion dollars over promotion of Vioxx. 2011. (Rofecoxib) https:\/\/www.justice.gov\/opa\/pr\/us-pharmaceutical-company-merck-sharp-dohme-pay-nearly-one-billion-dollars-over-promotion (Accessed September 15, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0058","unstructured":"Durkan J.A. (Assistant US Attorney, Western District of Washington). AMGEN Incorporated agrees to pay $762 million to resolve illegal marketing allegations. 2012. https:\/\/www.justice.gov\/archive\/usao\/waw\/press\/2012\/December\/amgen.html (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0059","unstructured":"Law360. Fresenius strikes $250 million deal to settle dialysis drug MDL. 2016. https:\/\/www.law360.com\/classaction\/articles\/760412\/fresenius-strikes-250m-deal-to-settle-dialysis-drug-mdl (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0060","unstructured":"McKee T. Johnson and Johnson to shell out $4 billion to settle hip suits? http:\/\/www.pharmatimes.com\/news\/j_and_j_to_shell_out_$4bn_to_settle_hip_suits_10060 (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0061","article-title":"Which is worse: avandia or Vioxx","author":"Herper","year":"2018","journal-title":"Fortune"},{"key":"10.1016\/j.eclinm.2020.100693_bib0062","unstructured":"Feeley J. Bayer set to pay out $60 million. bloomberg news. 2010. (150 cases- aprotonin) https:\/\/www.nydailynews.com\/news\/money\/bayer-pay-60m-heart-surgery-drug-settlement-article-1.204756 (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0063","unstructured":"PPA versus Chattem, Inc. United States district court, western district Washington 2004. https:\/\/casetext.com\/case\/in-re-ppa-prods-liability-litig (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0064","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bmj.39024.487720.68","article-title":"What have we learnt from Vioxx?","volume":"334","author":"Krumholz","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2020.100693_bib0065","unstructured":"Meeting briefing document oncology drug advisory committee epoetin alfa and darbepoetin. 2008 Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4345b2-05-amgen.pdf. (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0066","series-title":"Joint Meeting of the Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee","year":"2015"},{"key":"10.1016\/j.eclinm.2020.100693_bib0067","unstructured":"The Danish Medicines Agency. Report on omniscan. 2008. http:\/\/laegemiddelstyrelsen.dk\/en\/topics\/side-effects-and-trials\/side-effects\/news\/report-on-the-contrast-medium-omniscan (Accessed July 23, 2020)."},{"key":"10.1016\/j.eclinm.2020.100693_bib0068","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1056\/NEJMe1007445","article-title":"Don't mess with the DSMB","volume":"363","author":"Drazen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0069","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archinternmed.2011.618","article-title":"The FDA and new safety warnings","volume":"172","author":"Moore","year":"2012","journal-title":"Arch Intern Med"},{"issue":"14","key":"10.1016\/j.eclinm.2020.100693_bib0070","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMp048187","article-title":"Expecting the unexpected; Drug safety and the prepared mind","volume":"351","author":"Trontell","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0071","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMp048286","article-title":"Failing the public health: Rorecoxib, Merck, and the FDA","volume":"351","author":"Topol","year":"2004","journal-title":"New Eng J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0072","first-page":"18","article-title":"The FDA and drug safety: a proposal for sweeping changes","volume":"166","author":"Furberg","year":"2009","journal-title":"Arch Int Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0073","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJM199812173392512","article-title":"Making medicines safer \u2014 the need for an independent drug safety board","volume":"339","author":"Wood","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2020.100693_bib0074","first-page":"590","article-title":"Institutional corruption of pharmaceuticals and the myth of safe and effective drugs the journal of law","volume":"41","author":"Light","year":"2013","journal-title":"Medicine Ethics"},{"key":"10.1016\/j.eclinm.2020.100693_bib0075","article-title":"The role of black box warnings in safety prescribing","author":"Maggs","year":"2014","journal-title":"Health Affairs Blog."},{"issue":"6","key":"10.1016\/j.eclinm.2020.100693_bib0076","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1097\/MJT.0000000000000768","article-title":"Investigating serious adverse drug reactions in patients receiving erythropoiesis-stimulating agents: a root cause analysis using the \"ANTICIPATE\" framework","volume":"25","author":"Jacob","year":"2018","journal-title":"Am J Ther"},{"key":"10.1016\/j.eclinm.2020.100693_bib0077","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.293.17.2131","article-title":"The research on adverse drug events and reports (RADAR) project","volume":"293","author":"Bennett","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2020.100693_bib0078","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/eurheartj\/ehq016","article-title":"The rise and fall of rosiglitazone","volume":"7","author":"Nissen","year":"2010","journal-title":"Eur Heart J, Volume"},{"key":"10.1016\/j.eclinm.2020.100693_bib0079","unstructured":"Wall Street Journal. Glaxo's emails on avandia reveal concern. 2009. http:\/\/online.wsj.com\/article\/SB123190610976680477.htm"},{"key":"10.1016\/j.eclinm.2020.100693_bib0080","article-title":"Senators say Glaxo withheld drug data","author":"Mundy","year":"2010","journal-title":"The Wall Street Journal"},{"key":"10.1016\/j.eclinm.2020.100693_bib0081","article-title":"Anemia drugs made millions: but at what costs?","author":"Whoriskey","year":"2012","journal-title":"Washington Post"},{"key":"10.1016\/j.eclinm.2020.100693_bib0082","article-title":"FDA says Bayer refused to reveal drug risk study","author":"Harris","year":"2006","journal-title":"New York Times"},{"issue":"53","key":"10.1016\/j.eclinm.2020.100693_bib0083","first-page":"829","article-title":"Six years after","volume":"827-","author":"Thomsen","year":"2012","journal-title":"Acta radiol"},{"key":"10.1016\/j.eclinm.2020.100693_bib0084","article-title":"Plenty of villains, too many victims","author":"Steel","year":"2001","journal-title":"The Atlantic."},{"key":"10.1016\/j.eclinm.2020.100693_bib0085","article-title":"Diet pill saga","author":"McPherson","year":"1997","journal-title":"The Chicago Tribune"},{"key":"10.1016\/j.eclinm.2020.100693_bib0086","article-title":"GE violated Danish Law in Omniscan Case","author":"Gerth","year":"2010","journal-title":"Propublica."},{"key":"10.1016\/j.eclinm.2020.100693_bib0087","unstructured":"PPA versus Chattem, Inc. United states district court, Western District Washington 2004. https:\/\/casetext.com\/case\/in-re-ppa-prods-liability-litig (Accessed July 23, 2020)"},{"key":"10.1016\/j.eclinm.2020.100693_bib0088","article-title":"Jaw ailment shows industry moves slowly on drug warnings","author":"Anand","year":"2004","journal-title":"Wall Street J"},{"key":"10.1016\/j.eclinm.2020.100693_bib0089","article-title":"FDA asks Pfizer to suspend sales of Bextra: now there is only one available cox-2 inhibitor","author":"Apppleby","year":"2005","journal-title":"USA Today"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:04:15Z","timestamp":1762887855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020304375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":89,"alternative-id":["S2589537020304375"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100693","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997\u20132019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100693"}}